SPDR S&P Biotech ETF $XBI Shares Sold by Vontobel Holding Ltd.

Vontobel Holding Ltd. cut its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 83.0% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,230 shares of the exchange traded fund’s stock after selling 10,878 shares during the period. Vontobel Holding Ltd.’s holdings in SPDR S&P Biotech ETF were worth $223,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of XBI. AdvisorNet Financial Inc increased its holdings in shares of SPDR S&P Biotech ETF by 7.3% in the third quarter. AdvisorNet Financial Inc now owns 1,463 shares of the exchange traded fund’s stock valued at $147,000 after purchasing an additional 100 shares during the period. Investment Partners Asset Management Inc. grew its position in SPDR S&P Biotech ETF by 4.0% in the 2nd quarter. Investment Partners Asset Management Inc. now owns 3,257 shares of the exchange traded fund’s stock valued at $270,000 after buying an additional 125 shares during the last quarter. Compass Ion Advisors LLC increased its stake in SPDR S&P Biotech ETF by 3.9% in the 2nd quarter. Compass Ion Advisors LLC now owns 3,727 shares of the exchange traded fund’s stock valued at $309,000 after buying an additional 140 shares during the period. CWC Advisors LLC. raised its position in SPDR S&P Biotech ETF by 2.8% during the 3rd quarter. CWC Advisors LLC. now owns 5,707 shares of the exchange traded fund’s stock worth $572,000 after buying an additional 157 shares during the last quarter. Finally, McAdam LLC lifted its stake in shares of SPDR S&P Biotech ETF by 5.1% in the 2nd quarter. McAdam LLC now owns 3,273 shares of the exchange traded fund’s stock worth $271,000 after acquiring an additional 159 shares during the period.

SPDR S&P Biotech ETF Stock Down 1.4%

Shares of SPDR S&P Biotech ETF stock opened at $121.67 on Wednesday. The firm has a market cap of $7.39 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 52-week low of $66.66 and a 52-week high of $126.50. The company’s 50-day simple moving average is $117.58 and its 200-day simple moving average is $100.82.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.